FIGURE 5.

MRSA USA300 Counts following treatment with aurase, placebo and untreated controls compared with baseline. □ P < .05 compared with baseline and all treatments; * P < .05 compared with baseline, placebo and untreated controls; • P < .05 compared with baseline only.